Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,098 public trials 1,231 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Active, Not Recruiting

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

NCT03161431

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations
  • University of Miami Miami, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Post-Authorization Long-Term Safety Study of LUTATHERA

NCT03691064

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Banner MD Anderson Cancer Center Phoenix, Arizona, United States
  • The Ohio State University Wexner Medical Center Portland, Ohio, United States
  • Oregon Health & Sciences University Hospital Portland, Oregon, United States
  • Virginia Mason in Seattle Seattle, Washington, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

NCT03600233

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations
  • Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Active, Not Recruiting

SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)

NCT04079166

Conditions
Malignant Melanoma, Melanoma, Melanoma (Skin), +13 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Velindre University NHS Trust Cardiff, United Kingdom
  • The Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
  • Guy's & St Thomas' NHS Foundation Trust London, United Kingdom
View all 15 locations
View Trial Details
Active, Not Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details

Related conditions